Evonik Expands Excipients Portfolio, Launches MaxiPure Polysorbate 80 for Injectable Formulations
Engineered to meet the stringent demands of modern drug development, Evonik's MaxiPure Polysorbate 80 addresses key challenges such as protein stability, viral inactivation, and the consistent solubilisation of hydrophobic active pharmaceutical ingredients (APIs).
Non-ionic Surfactant | 24/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy